Risk Factors for Postpartum Hemorrhage in Patients With Histologically Verified Placenta Accreta
1 other identifier
observational
2,348
1 country
1
Brief Summary
This retrospective, monocentric study aims to examine risk factors for postpartum hemorrhage in women with histologically verified placenta accreta. Women with histologically verified placenta accreta are divided into two groups: women with normal blood loss (BV \< 500 ml) versus women with increased blood loss (BV ≥ 500 ml). The clinical data of pregnant women with histologically verified placental disorders, who gave birth in the Women's Clinic University Hospital Basel (USB) between 1986 and 2019, are compared with each other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedFirst Submitted
Initial submission to the registry
September 5, 2022
CompletedFirst Posted
Study publicly available on registry
September 15, 2022
CompletedDecember 7, 2022
December 1, 2022
1.3 years
September 5, 2022
December 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of Placenta praevia
Descriptive analysis: Number of women with Placenta praevia (in women with PPH (blood loss ≥ 500 ml) compared to women with normal blood loss (\< 500 ml))
one time assessment at baseline
Number of Caesarean sections
Descriptive analysis: Number of women with Caesarean section (in women with PPH (blood loss ≥ 500 ml) compared to women with normal blood loss (\< 500 ml))
one time assessment at baseline
Number of women with obesity
Descriptive analysis: Number of pregnant women with obesity (in women with PPH (blood loss ≥ 500 ml) compared to women with normal blood loss (\< 500 ml))
one time assessment at baseline
Increased maternal age
Descriptive analysis: Number of pregnant women with increased maternal age (in women with PPH (blood loss ≥ 500 ml) compared to women with normal blood loss (\< 500 ml))
one time assessment at baseline
Study Arms (2)
Women with normal blood loss (BV < 500 mL)
Women with increased blood loss (BV ≥ 500 mL)
Interventions
The data includes anamnestic and clinical data from women whose placental histology reveals a diagnosis of placental dysfunction. Maternal data on the following characteristics: age, ethnicity, BMI, pregnancy, parity, number of abortions without curettage, multiple births, previous birth mode. Risk factors for placentation disorders (increased maternal age, increased pregnancy and parity, increased BMI, placenta previa, nicotine abuse, multiple births, hypertension, diabetes, infections, bleeding, abortion curettage, hysteroscopy ± cavum curettage, caesarean section, fibroid removal, Asherman' s syndrome, status after IVF, endometritis) and birth mode. Data on peripartal and postpartum surgical measures.
Eligibility Criteria
Pregnant women with histologically verified placental disorder who gave birth in the USB women's clinic between 1986 and 2019.
You may qualify if:
- Pregnant women with a histologically verified placental disorder who gave birth at the Women's Hospital USB between 1986 and 2019
You may not qualify if:
- Existence of a documented refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Basel, Women's Clinic, Obstetrics and pregnancy medicine
Basel, 4031, Switzerland
Related Publications (1)
Ghaem Maghami N, Helfenstein F, Manegold-Brauer G, Amstad G. Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: a retrospective single-centre cross-sectional study. BMC Pregnancy Childbirth. 2023 Nov 11;23(1):786. doi: 10.1186/s12884-023-06103-5.
PMID: 37951863DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Irene Hoesli, Prof. Dr. med.
University Hospital Basel, Women's Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2022
First Posted
September 15, 2022
Study Start
July 1, 2020
Primary Completion
October 31, 2021
Study Completion
October 31, 2021
Last Updated
December 7, 2022
Record last verified: 2022-12